RAPT Therapeutics, Inc. (RAPT)
Largest Insider Buys in Sector
RAPT Stock Price History Chart
RAPT Stock Performance
About RAPT Therapeutics, Inc.
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development of hematopoietic progenitor kinase 1 inhibitor. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
Insider Activity of RAPT Therapeutics, Inc.
Over the last 12 months, insiders at RAPT Therapeutics, Inc. have bought $0 and sold $181,961 worth of RAPT Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at RAPT Therapeutics, Inc. have bought $8.8M and sold $29.44M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,000 shares for transaction amount of $97,612 was made by Robbins Wendye (director) on 2023‑03‑14.
List of Insider Buy and Sell Transactions, RAPT Therapeutics, Inc.
| 2024-01-05 | Sale | Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | 898 0.0025% | $22.78 | $20,456 | -64.37% | |
| 2023-12-21 | Sale | HO WILLIAM | Chief Medical Officer | 2,500 0.007% | $21.68 | $54,200 | -62.24% | |
| 2023-11-28 | Sale | HO WILLIAM | Chief Medical Officer | 1,500 0.0042% | $13.72 | $20,580 | -39.13% | |
| 2023-10-03 | Sale | HO WILLIAM | Chief Medical Officer | 2,500 0.0072% | $15.77 | $39,425 | -24.49% | |
| 2023-08-18 | Sale | HO WILLIAM | Chief Medical Officer | 2,500 0.0072% | $18.92 | $47,300 | -30.97% | |
| 2023-04-19 | Sale | HO WILLIAM | Chief Medical Officer | 5,000 0.015% | $18.88 | $94,400 | -1.14% | |
| 2023-03-14 | Robbins Wendye | director | 5,000 0.0152% | $19.52 | $97,612 | -2.84% | ||
| 2023-03-07 | Sale | HO WILLIAM | 5,000 0.015% | $29.62 | $148,100 | -36.53% | ||
| 2023-01-24 | Sale | HO WILLIAM | Chief Medical Officer | 5,000 0.0162% | $30.00 | $150,000 | -31.27% | |
| 2023-01-19 | Sale | HO WILLIAM | Chief Medical Officer | 5,000 0.0146% | $25.56 | $127,800 | -27.26% | |
| 2023-01-05 | Sale | Brockstedt Dirk G. | Chief Scientific Officer | 742 0.0022% | $21.97 | $16,299 | -13.46% | |
| 2022-12-29 | Sale | HO WILLIAM | Chief Medical Officer | 5,000 0.0132% | $18.03 | $90,150 | +2.33% | |
| 2022-11-28 | Sale | HO WILLIAM | Chief Medical Officer | 5,000 0.0144% | $17.87 | $89,350 | +10.70% | |
| 2022-11-02 | Sale | HO WILLIAM | Chief Medical Officer | 5,000 0.0144% | $22.32 | $111,600 | -10.51% | |
| 2022-10-13 | Sale | HO WILLIAM | Chief Medical Officer | 2,000 0.0054% | $21.52 | $43,040 | -10.07% | |
| 2022-08-30 | Sale | HO WILLIAM | Chief Medical Officer | 2,500 0.0079% | $28.13 | $70,325 | -20.41% | |
| 2022-07-11 | Sale | HO WILLIAM | Chief Medical Officer | 2,000 0.006% | $19.95 | $39,900 | +6.92% | |
| 2022-05-25 | Column Group LLC | 1,837 0.0054% | $12.45 | $22,880 | +54.33% | |||
| 2022-05-25 | TCG IV GP, LLC | 63 0.0002% | $12.45 | $785 | +54.33% | |||
| 2022-05-23 | Column Group LLC | 15,776 0.0484% | $12.00 | $189,345 | +67.60% |
Insider Historical Profitability
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | 27820 0.0809% | $3.05 | 0 | 23 | |
| HO WILLIAM | Chief Medical Officer | 15020 0.0437% | $3.05 | 0 | 56 | |
| GOEDDEL DAVID V | director | 4982333 14.4851% | $3.05 | 1 | 0 | +107.48% |
| Svennilson Peter | director | 3835679 11.1515% | $3.05 | 0 | 2 | |
| Topspin Fund L.P. | director | 2575371 7.4874% | $3.05 | 1 | 0 | +107.48% |
| Column Group LLC | 1236261 3.5942% | $3.05 | 3 | 0 | +69.16% | |
| Wong Brian Russell | President and CEO | 337000 0.9798% | $3.05 | 2 | 1 | +43.65% |
| TCG IV GP, LLC | 42189 0.1227% | $3.05 | 3 | 0 | +69.16% | |
| RIEFLIN WILLIAM JL | director | 18000 0.0523% | $3.05 | 2 | 0 | +75.34% |
| Robbins Wendye | director | 14900 0.0433% | $3.05 | 18 | 0 | +7.41% |
| Lam Karen C | VP, Finance and Controller | 12735 0.037% | $3.05 | 0 | 3 | |
| Young Rodney KB | Chief Financial Officer | 10084 0.0293% | $3.05 | 1 | 0 | +85.56% |
| Giordano Michael F | director | 0 0% | $3.05 | 0 | 1 | |
| COLUMN GROUP II, LP | 10 percent owner | 0 0% | $3.05 | 1 | 8 | +107.48% |
Institutional Investor Ownership
| Fidelity Investments | $46.87M | 15 | 5.22M | +35.81% | +$12.36M | <0.01 | |
| Column Group Llc | $24.07M | 7.7 | 2.68M | 0% | +$0 | 18.28 | |
| The Vanguard Group | $22.39M | 7.16 | 2.49M | +21.23% | +$3.92M | <0.0001 | |
| BlackRock | $22.2M | 7.1 | 2.47M | +0.78% | +$171,553.91 | <0.01 | |
| T. Rowe Price | $18.21M | 5.83 | 2.03M | -40.59% | -$12.44M | <0.01 | |
| Morgan Stanley | $17.11M | 5.48 | 1.91M | +82.27% | +$7.72M | <0.01 | |
| Kingdon Capital Management | $13.47M | 4.31 | 1.5M | +55.31% | +$4.8M | 1.78 | |
| Perceptive Advisors | $10.99M | 3.52 | 1.22M | -42.83% | -$8.23M | 0.01 | |
| Geode Capital Management | $6.1M | 1.95 | 679,216 | +1.48% | +$89,066.55 | <0.01 | |
| Redmile Group | $5.95M | 1.9 | 662,398 | +80.6% | +$2.65M | 0.22 | |
| State Street | $5.92M | 1.9 | 659,402 | -54.67% | -$7.14M | <0.0001 | |
| Euclidean Capital Llc | $5.91M | 1.89 | 657,899 | 0% | +$0 | 0.76 | |
| Dimensional Fund Advisors | $5M | 1.6 | 556,804 | +14.03% | +$615,291.65 | <0.01 | |
| Alphabet | $4.85M | 1.55 | 540,270 | 0% | +$0 | 0.19 | |
| Cormorant Asset Management Lp | $4.46M | 1.43 | 496,750 | 0% | +$0 | 0.21 | |
| Two Sigma | $3.82M | 1.22 | 425,603 | +1,203.89% | +$3.53M | 0.01 | |
| Ally Bridge Group | $3.77M | 1.21 | 420,000 | New | +$3.77M | 2.12 | |
| Ardsley Advisory Partners | $3.61M | 1.16 | 402,500 | New | +$3.61M | 0.52 | |
| Two Sigma Advisers LP | $3.08M | 0.98 | 342,500 | +435.16% | +$2.5M | 0.01 | |
| Woodline Partners LP | $2.89M | 0.92 | 321,613 | +59.85% | +$1.08M | 0.03 | |
| Sio Capital Management LLC | $2.83M | 0.91 | 315,000 | New | +$2.83M | 1 | |
| Candriam S C A | $2.81M | 0.9 | 313,262 | 0% | +$0 | 0.02 | |
| Northern Trust | $2.66M | 0.85 | 296,453 | -2.8% | -$76,635.32 | <0.0001 | |
| Octagon Capital Advisors LP | $2.62M | 0.84 | 292,000 | 0% | +$0 | 0.34 | |
| Deutsche Bank | $2.6M | 0.83 | 289,510 | -0.22% | -$5,729.24 | <0.01 | |
| Federated Hermes | $2.48M | 0.79 | 275,712 | New | +$2.48M | 0.01 | |
| Ubs Asset Management Americas Inc | $2.47M | 0.79 | 275,097 | -0.28% | -$6,896.64 | <0.01 | |
| D. E. Shaw & Co. | $2.43M | 0.78 | 270,141 | New | +$2.43M | <0.01 | |
| Millennium Management LLC | $2.17M | 0.7 | 242,155 | -45.55% | -$1.82M | <0.01 | |
| Citadel Advisors LLC | $2.17M | 0.7 | 241,783 | +143.81% | +$1.28M | <0.01 | |
| Charles Schwab | $2.12M | 0.68 | 235,656 | +0.52% | +$10,928.66 | <0.0001 | |
| Goldman Sachs | $1.67M | 0.54 | 186,223 | -5.12% | -$90,302.90 | <0.0001 | |
| Trexquant Investment LP | $1.42M | 0.45 | 157,642 | New | +$1.42M | 0.02 | |
| Ikarian Capital LLC | $1.39M | 0.44 | 154,625 | New | +$1.39M | 0.4 | |
| Artia Global Partners Lp | $1.23M | 0.4 | 137,308 | +599.2% | +$1.06M | 0.31 | |
| Jane Street Capital | $1.08M | 0.35 | 120,765 | +58.13% | +$398,649.25 | <0.01 | |
| Caption Management Llc | $985,555.00 | 0.32 | 109,750 | +113.94% | +$524,881.00 | 0.03 | |
| Bank of America | $981,110.00 | 0.31 | 109,255 | +16.96% | +$142,297.09 | <0.0001 | |
| Nuveen | $951,961.00 | 0.31 | 106,009 | +2.38% | +$22,108.76 | <0.0001 | |
| Renaissance Technologies | $880,000.00 | 0.28 | 98,000 | New | +$880,000.00 | <0.01 | |
| Barclays | $831,000.00 | 0.27 | 92,617 | +18.02% | +$126,906.12 | <0.0001 | |
| BNY Mellon | $829,887.00 | 0.27 | 92,415 | -9.24% | -$84,492.85 | <0.0001 | |
| Wellington Management Company | $724,165.00 | 0.23 | 80,642 | New | +$724,165.00 | <0.0001 | |
| Walleye Capital | $695,169.00 | 0.22 | 77,413 | New | +$695,169.00 | <0.01 | |
| Ubs Oconnor Llc | $656,330.00 | 0.21 | 73,088 | +18.09% | +$100,566.98 | 0.06 | |
| Susquehanna International Group | $556,527.00 | 0.18 | 61,974 | +249.52% | +$397,302.48 | <0.01 | |
| Voya Investment Management LLC | $555,269.00 | 0.18 | 61,834 | -3.1% | -$17,762.43 | <0.01 | |
| Balyasny Asset Management Llc | $520,436.00 | 0.17 | 57,955 | New | +$520,436.00 | <0.01 | |
| UBS | $498,991.00 | 0.16 | 55,567 | -38.27% | -$309,297.73 | <0.0001 | |
| Algert Global LLC | $484,000.00 | 0.16 | 53,888 | +53.4% | +$168,476.69 | 0.02 |